Drugs / GK Activator (2)
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT00437606 | Mar → Jun 2007 | type 2 diabetes mellitus | Hoffmann-La Roche | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT00388986 | Oct 2006 → Jul 2007 | type 2 diabetes mellitus | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 1 | NCT00377442 | Aug 2006 → Apr 2007 | type 2 diabetes mellitus | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 1 | NCT00368368 | Jan 2006 → Aug 2007 | type 2 diabetes mellitus | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 24 trials | ||||||
| Phase 2 | NCT00366379 | Jul 2006 → Jun 2007 | type 2 diabetes mellitus | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 2 | NCT00316758 | Feb 2006 → Oct 2007 | type 2 diabetes mellitus | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 2 | NCT00266253 | Nov 2005 → Mar 2007 | type 2 diabetes mellitus | Hoffmann-La Roche | Completed | No outcome recorded |
| Phase 2 | NCT00266240 | Nov 2005 → May 2007 | type 2 diabetes mellitus | Hoffmann-La Roche | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GK Activator (2) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00377442 ↗ |
| Action | Activate | “GK Activator (2)” NCT00266240 ↗ |
| Route | Oral | “oral GK Activator (2)” NCT00266240 ↗ |